litlas
Log inCreate account

D. Allan Butterfield

Active 1974–2025

288
Papers
55,473
Citations
135
h-index
287
i10-index

Citations

Citations per year for D. Allan Butterfield1976: 4 citations1977: 6 citations1978: 5 citations1980: 1 citations1982: 4 citations1984: 2 citations1987: 1 citations1992: 1 citations1993: 1 citations1994: 8 citations1995: 35 citations1996: 46 citations1997: 123 citations1998: 110 citations1999: 148 citations2000: 192 citations2001: 228 citations2002: 455 citations2003: 310 citations2004: 653 citations2005: 710 citations2006: 898 citations2007: 714 citations2008: 741 citations2009: 885 citations2010: 878 citations2011: 1,002 citations2012: 778 citations2013: 771 citations2014: 752 citations2015: 621 citations2016: 681 citations2017: 575 citations2018: 687 citations2019: 1,616 citations2020: 2,101 citations2021: 1,930 citations2022: 1,404 citations2023: 1,287 citations2024: 1,571 citations2025: 798 citations2026: 17 citations1979: no citations, so this year is not shown1981: no citations, so this year is not shown1983: no citations, so this year is not shown1985–1986: no citations, so these years are not shown1988–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,361 citing papers, 23.9% of this breakdownChina: 2,390 citing papers, 13.1% of this breakdownItaly: 1,154 citing papers, 6.3% of this breakdownIndia: 875 citing papers, 4.8% of this breakdownUnited Kingdom: 766 citing papers, 4.2% of this breakdownSpain: 564 citing papers, 3.1% of this breakdownGermany: 563 citing papers, 3.1% of this breakdownCanada: 487 citing papers, 2.7% of this breakdownAustralia: 480 citing papers, 2.6% of this breakdownJapan: 480 citing papers, 2.6% of this breakdownSouth Korea: 469 citing papers, 2.6% of this breakdownFrance: 355 citing papers, 1.9% of this breakdown
0%23.9%Other 29.1%

Institutions

Fields

  • Medicine47.7%
  • Biochemistry, Genetics and Molecular Biology27.2%
  • Neuroscience12%
  • Agricultural and Biological Sciences3.2%
  • Nursing1.9%
  • Chemistry1.7%
  • Other6.3%

Topics

  • Alzheimer's disease research and treatments10.2%
  • Cholinesterase and Neurodegenerative Diseases3.3%
  • Neuroinflammation and Neurodegeneration Mechanisms3.1%
  • Mitochondrial Function and Pathology2.8%
  • Tryptophan and brain disorders2.4%
  • Neuroscience and Neuropharmacology Research1.8%
  • Other76.4%

Coauthors

All papers

Open in search
  1. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease

    Authors: D. Allan Butterfield, Barry Halliwell - Nature reviews. Neuroscience 2019 cited by 1,902

  2. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity

    Authors: Vittorio Calabrese, Cesare Mancuso, Menotti Calvani, Enrico Rizzarelli, D. Allan Butterfield, A. M. Giuffrida Stella - Nature reviews. Neuroscience 2007 cited by 1,527

  3. Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease

    Authors: Marzia Perluigi, Fabio Di Domenico, D. Allan Butterfield - Physiological Reviews 2023 cited by 233

  4. Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease

    Authors: D. Allan Butterfield, Debra Boyd‐Kimball - Journal of Alzheimer s Disease 2018 cited by 399

  5. The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease

    Authors: Eugenio Barone, Fabio Di Domenico, Marzia Perluigi, D. Allan Butterfield - Free Radical Biology and Medicine 2021 cited by 171

  6. Measurement of Oxidized/Reduced Glutathione Ratio

    Authors: Joshua B. Owen, D. Allan Butterfield - Methods in molecular biology 2010 cited by 411

  7. Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer disease brain

    Authors: Rukhsana Sultana, Marzia Perluigi, D. Allan Butterfield - Free Radical Biology and Medicine 2012 cited by 480

  8. Amyloid β -Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression

    Authors: D. Allan Butterfield, Aaron M. Swomley, Rukhsana Sultana - Antioxidants and Redox Signaling 2012 cited by 522

  9. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD

    Authors: Antonella Tramutola, Judy C. Triplett, Fabio Di Domenico, Dana M. Niedowicz, Michael P. Murphy, Raffaella Coccia, Marzia Perluigi, D. Allan Butterfield - Journal of Neurochemistry 2015 cited by 344

  10. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders

    Authors: Fabio Di Domenico, Antonella Tramutola, D. Allan Butterfield - Free Radical Biology and Medicine 2016 cited by 251

  11. mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder

    Authors: Marzia Perluigi, Fabio Di Domenico, Eugenio Barone, D. Allan Butterfield - Free Radical Biology and Medicine 2021 cited by 125

  12. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease

    Authors: D. Allan Butterfield, Mark P. Mattson - Neurobiology of Disease 2020 cited by 189

  13. Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress

    Authors: Nicole Rummel, D. Allan Butterfield - Antioxidants and Redox Signaling 2021 cited by 102

  14. mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy

    Authors: Marzia Perluigi, Fabio Di Domenico, D. Allan Butterfield - Neurobiology of Disease 2015 cited by 345

  15. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide

    Authors: D. Allan Butterfield, Jennifer Drake, Chava B. Pocernich, Alessandra Castegna - Trends in Molecular Medicine 2001 cited by 1,112

  16. Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain

    Authors: D. Allan Butterfield, Fabio Di Domenico, Eugenio Barone - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014 cited by 402

  17. Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration

    Authors: Yekaterina Y. Zaytseva, Jennifer W. Harris, Mihail I. Mitov, Ji Tae Kim, D. Allan Butterfield, Eun Y. Lee, Heidi L. Weiss, Tianyan Gao, B. Mark Evers - Oncotarget 2015 cited by 152

  18. Brain lipid peroxidation and alzheimer disease: Synergy between the Butterfield and Mattson laboratories

    Authors: D. Allan Butterfield - Ageing Research Reviews 2020 cited by 92

  19. Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress

    Authors: D. Allan Butterfield, Christopher M. Lauderback - Free Radical Biology and Medicine 2002 cited by 995

  20. Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

    Authors: D. Allan Butterfield, Tanea T. Reed, Shelley F. Newman, Rukhsana Sultana - Free Radical Biology and Medicine 2007 cited by 561

  21. Protective effect of quercetin in primary neurons against Aβ(1–42): relevance to Alzheimer's disease

    Authors: Mubeen A. Ansari, Hafiz Mohammad Abdul, Gururaj Joshi, Wycliffe O. Opii, D. Allan Butterfield - The Journal of Nutritional Biochemistry 2008 cited by 419

  22. Oxidative stress, protein modification and Alzheimer disease

    Authors: Antonella Tramutola, Chiara Lanzillotta, Marzia Perluigi, D. Allan Butterfield - Brain Research Bulletin 2016 cited by 302

  23. Protective Effect of Carnosine During Nitrosative Stress in Astroglial Cell Cultures

    Authors: Vittorio Calabrese, Claudia Colombrita, Eleonora Guagliano, Maria Sapienza, Agrippino Ravagna, Venera Cardile, Giovanni Scapagnini, Anna Maria Santoro, A Mangiameli, D. Allan Butterfield, A. M. Giuffrida Stella, Enrico Rizzarelli - Neurochemical Research 2005 cited by 119

  24. Disruption of the hippocampal and hypothalamic blood–brain barrier in a diet-induced obese model of type II diabetes: prevention and treatment by the mitochondrial carbonic anhydrase inhibitor, topiramate

    Authors: Therese S. Salameh, William G. Mortell, Aric F. Logsdon, D. Allan Butterfield, William A. Banks - Fluids and Barriers of the CNS 2019 cited by 119